AKRX stock forecast
Our latest prediction for Akorn, Inc.'s stock price was made on the Jan. 25, 2018 when the stock price was at 32.59$.
In the short term (2weeks), AKRX's stock price should outperform the market by 0.15%. During that period the price should oscillate between -3.64% and +3.65%.
In the medium term (3months), AKRX's stock price should outperform the market by 0.89%. During that period the price should oscillate between -9.30% and +10.76%.Get email alerts
Create a solid portfolio with AKRX
About Akorn, Inc.
Akorn, Inc. engages in the development, manufacture, and marketing of generic and prescription pharmaceuticals, and animal and consumer health products. It operates through the Prescription Pharmaceuticals and Consumer Health business segments. The Prescription Pharmaceuticals segment manufactures and markets generic and branded prescription pharmaceuticals including ophthalmic, injectable, oral liquids, topical, inhalants, and nasal sprays. The Consumer Health segment offers branded and private-label animal health; and over-the-counter products. The company was founded in 1971 and is headquartered in Lake Forest, IL.
At the moment the company generates 682M USD in revenues.
On its last earning announcement, the company reported a loss of -1.80$ per share.
The book value per share is 5.75$
Three months stock forecastJan. 25, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|